Abstract: A photoacid generator includes those of formula (I): wherein each Ra in formula 1 is independently H, F, a C1-10 nonfluorinated organic group, C1-10 fluorinated organic group, or a combination comprising at least one of the foregoing, provided at least one Ra is F or a C1-10 fluorinated organic group, the C1-10 fluorinated and nonfluorinated organic groups each optionally comprising O, S, N, or a combination comprising at least one of the foregoing heteroatoms; L1 is a linking group comprising a heteroatom comprising O, S, N, F, or a combination comprising at least one of the foregoing; G+ is an onium salt of the formula (II): wherein in formula (II), X is S or I, each R0 is independently C1-30 alkyl group; a polycyclic or monocyclic C3-30 cycloalkyl group; a polycyclic or monocyclic C4-30 aryl group; or a combination comprising at least one of the foregoing, provided at least one R0 is substituted where each R0 is a C6 monocyclic aryl group, and wherein when X is I, a is 2, and where X is S, a is 3,

Abstract: A photoacid generator compound has the formula (I): [A-(CHR1)p]k-(L)-(CH2)m—(C(R2)2)n—SO3?Z+??(I) wherein A is a substituted or unsubstituted, monocyclic, polycyclic, or fused polycyclic C5 or greater cycloaliphatic group optionally comprising O, S, N, F, or a combination comprising at least one of the foregoing, R1 is H, a single bond, or a substituted or unsubstituted C1-30 alkyl group, wherein when R1 is a single bond, R1 is covalently bonded to a carbon atom of A, each R2 is independently H, F, or C1-4 fluoroalkyl, wherein at least one R2 is not hydrogen, L is a linking group comprising a sulfonate group, a sulfonamide group, or a C1-30 sulfonate or sulfonamide-containing group, Z is an organic or inorganic cation, p is an integer of 0 to 10,k is 1 or 2, m is an integer of 0 or greater, and n is an integer of 1 or greater.

Abstract: A process to prepare fluorinated sulfobetaine compounds of formula (I) wherein Rf is C2 to C10 fluoroalkyl optionally interrupted by one or more of O, CH2, CHF, or combinations thereof; R1 is C1 to C10 alkylene; R2 is C1 to C6 alkylene or a chemical bond; R3 is H or CH3; R4 is C1 to C6 alkylene containing at least one hydroxyl group; R5 is H or CH3; and R6 is H or CH3; comprising contacting a fluorinated sulfonamide amine of formula (II) with an aliphatic chlorosulfonic acid or salt thereof of formula (III) in the presence of water and at least one alkylene glycol, and optionally at least one alkyl carbonate, said fluorinated sulfobetaine having reduced free chloride content and reduced flammability without the need for additional purification steps.

Abstract: Embodiments are related to ionic liquids and more specifically to ionic liquids used in electrochemical metal-air cells in which the ionic liquid includes sulfonate ions as the anion.

Abstract: A process to prepare fluorinated sulfobetaine compounds of formula (I) wherein Rf is C2 to C10 fluoroalkyl optionally interrupted by one or more of O, CH2, CHF, or combinations thereof; R1 is C1 to C10 alkylene; R2 is C1 to C6 alkylene or a chemical bond; R3 is H or CH3; R4 is C1 to C6 alkylene containing at least one hydroxyl group; R5 is H or CH3; and R6 is H or CH3; comprising contacting a fluorinated sulfonamide amine of formula (II) with an aliphatic chlorosulfonic acid or salt thereof of formula (III) in the presence of water and at least one alkylene glycol, and optionally at least one alkyl carbonate, said fluorinated sulfobetaine having reduced free chloride content and reduced flammability without the need for additional purification steps.

Abstract: A fluorine-containing compound exhibiting excellent surface tension-reducing ability despite the absence of perfluoroalkyl group having a chain length of 8 or more which had been the cause of the PFOS and PFOA problems and use of a fluorine material with low environmental load is provided. Also provided are a fluorine-containing surfactant and a composition thereof, an aqueous resin emulsion and a floor polish composition containing such surfactant. The fluorine-containing compound is represented by the following formula (1): Rf1—CpH2p—CH(OH)—CqH2q—NR—CrH2r—(O)n—SO3M (1) wherein Rf1 is a C1-6 perfluoroalkyl group, p, q, and r are independently an integer of 1 to 6, M is a cationic atom or atomic group, n is 0 or 1, R is hydrogen atom, a C1-12 alkyl group, or a group represented by the following formula (2): Rf2—CsH2s—CH(OH)—CtH2t—??(2) wherein Rf2 is a C1-6 perfluoroalkyl group, and s and t are independently an integer of 1 to 6.

Abstract: Quaternary ammonium, betaine, or sulfobetaine compositions derived from fatty amines, wherein the fatty amine is made by reducing the amide reaction product of a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives and a secondary amine, are disclosed. Quaternary ammonium, betaine, or sulfobetaine compositions derived from fatty amidoamines, wherein the amidoamine is made by reacting of a metathesis-derived C10-C17 monounsaturated acid, octadecene-1,18-dioic acid, or their ester derivatives and an aminoalkyl-substituted tertiary amine, are also disclosed. The quaternized compositions are advantageously sulfonated or sulfated. In one aspect, the ester derivative of the C10-C17 monoun-saturated acid or octadecene-1,18-dioic acid is a lower alkyl ester. In other aspects, the ester derivative is a modified triglyceride made by self-metathesis of a natural oil or an unsaturated triglyceride made by cross-metathesis of a natural oil with an olefin.

Abstract: The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.

Abstract: Sulfonate-, sulfate-, or carboxylate-capped, alkoxylated anti-misting agents having the structure: R((AO)nX)m((AO)nH)p, and methods of suppressing mist from electrolyte solutions by adding a mist-suppressing amount of one or more compounds selected from the group consisting of compounds of the Formulas R((AO)nX)m((AO)nH)p and R3N+(CH3)2R4, and mixtures thereof, to electrolyte solutions.

Abstract: The present invention relates to the novel compound classes of dendritic polyglycerol sulfates and sultanates as well as to their production and use for the treatment of diseases, particularly inflammatory diseases, and to their use as selectin inhibitors and selectin indicators. The dendritic polyglycerol sulfates and sulfonates are also suitable for imaging diagnostics, particularly with respect to inflammatory diseases.

Abstract: Embodiments are related to ionic liquids and more specifically to ionic liquids used in electrochemical metal-air cells in which the ionic liquid includes sulfonate ions as the anion.

Abstract: Amines and amine derivatives that improve the buffering range, and/or reduce the chelation and other negative interactions of the buffer and the system to be buffered. The reaction of amines or polyamines with various molecules to form polyamines with differing pKa's will extend the buffering range, derivatives that result in polyamines that have the same pKa yields a greater buffering capacity. Derivatives that result in zwitterionic buffers improve yield by allowing a greater range of stability.

Abstract: To provide a parakeratosis inhibitor, pore reducing agent and skin roughness preventing/ameliorating agent that exhibit capabilities of parakeratosis inhibition, pore reduction, skin roughness prevention/amelioration, etc., and further provide a skin preparation for external use having these capabilities. There are provided a parakeratosis inhibitor, a pore reducing agent and a skin roughness preventing/ameliorating agent each comprising at least one compound selected from the group consisting of specified glycine derivatives and salts thereof and specified aminosulfuric acid derivatives and salts thereof. Still further, there are provided skin preparations for external use comprising these compounds.

Abstract: A fluorine-containing compound exhibiting excellent surface tension-reducing ability despite the absence of perfluoroalkyl group having a chain length of 8 or more which had been the cause of the PFOS and PFOA problems and use of a fluorine material with low environmental load is provided. Also provided are a fluorine-containing surfactant and a composition thereof, an aqueous resin emulsion and a floor polish composition containing such surfactant. The fluorine-containing compound is represented by the following formula (1): Rf1—CpH2p—CH(OH)—CqH2q—NR—CrH2r—(O)n—SO3M??(1) wherein Rf1 is a C1-6 perfluoroalkyl group, p, q, and r are independently an integer of 1 to 6, M is a cationic atom or atomic group, n is 0 or 1, R is hydrogen atom, a C1-12 alkyl group, or a group represented by the following formula (2): Rf2—CsH2s—CH(OH)—CtH2t—??(2) wherein Rf2 is a C1-6 perfluoroalkyl group, and s and t are independently an integer of 1 to 6.

Abstract: To provide a parakeratosis inhibitor, pore reducing agent and skin roughness preventing/ameliorating agent that exhibit capabilities of parakeratosis inhibition, pore reduction, skin roughness prevention/amelioration, etc., and further provide a skin preparation for external use having these capabilities. There are provide a parakeratosis inhibitor and a pore reducing agent each comprising at least one compound selected from the group consisting of a glycine derivative, an aminodicarboxylic acid derivative, an acylaminodicarboxylic acid derivative, a pyrrolidinecarboxylic acid derivative, a piperidinecarboxylic acid derivative, a hexamethyleneiminecarboxylic acid, a beta-alanine derivative and salts of these derivatives.

Abstract: Methods of detecting at least one analyte and at least one nucleic acid in a sample are provided. Reagents for carrying out the methods are also provided.

Abstract: The present invention provides a composition for inhibiting melanin production to promote skin whitening, which is characterized by containing compounds represented by formula (I): wherein R1, R2 and R3 are defined as herein. The present invention also provides a method for inhibiting melanin production to promote skin whitening by using the same.

Abstract: Provided are methionine analogs which may be useful for inhibiting protein synthesis, inhibiting microbial growth and/or treating infectious diseases. In some instances, the analogs exhibit bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and/or antiviral properties. Also provided are methods of treatment and methods of preparation, as well as kits and unit dosages.

Abstract: Amines and amine derivatives that improve the buffering range, and/or reduce the chelation and other negative interactions of the buffer and the system to be buffered. The reaction of amines or polyamines with various molecules to form polyamines with differing pKa's will extend the buffering range, derivatives that result in polyamines that have the same pKa yields a greater buffering capacity. Derivatives that result in zwitterionic buffers improve yield by allowing a greater range of stability.

Abstract: The present invention relates to active bactericidal, antibacterial, anti-infective, antimicrobial, sporicidal, disinfectant, antifungal and antiviral compounds and compositions and to new uses of these compositions in therapy. This specification also describes methods of use for the new compounds and compositions. The specification further describes methods for preparing these compounds.

Abstract: Amines and amine derivatives that improve the buffering range, and/or reduce the chelation and other negative interactions of the buffer and the system to be buffered. The reaction of amines or polyamines with various molecules to form polyamines with differing pKa's will extend the buffering range, derivatives that result in polyamines that have the same pKa yields a greater buffering capacity. Derivatives that result in zwitterionic buffers improve yield by allowing a greater range of stability.

Abstract: Amines and amine derivatives that improve the buffering range, and/or reduce the chelation and other negative interactions of the buffer and the system to be buffered. The reaction of amines or polyamines with various molecules to form polyamines with differing pKa's will extend the buffering range, derivatives that result in polyamines that have the same pKa yields a greater buffering capacity. Derivatives that result in zwitterionic buffers improve yield by allowing a greater range of stability.

Abstract: Perfluoroalkyl-substituted amines, acids, amino acids and thioether acid compounds containing a perfluoroalkyl-iodoalkyl or perfluoroalkyl-alkene group as well as derivatives thereof, are described. They are useful as surfactants in a variety of applications where low surface tensions are required, including coating formulations for glass, wood, metal, cement, paper, textiles, as foam control agents in polyurethane foams and especially in aqueous fire-fighting formulations.

Abstract: The present invention solves the problem of soil and dirt becoming entrained in cellulosic material loosened and removed from fabric during washing wherein said dirt and soil is entrapped by the cellulosic material and re-deposited onto the fabric surface. The compositions of the present invention comprise: a) from about 0.01% by weight, of a zwitterionic polyamine which comprises a polyamine backbone, said backbone comprising two or more amino units wherein at least one of said amino units is quaternized and wherein at least one amino unit is substituted by one or more moieties capable of having an anionic charge wherein further the number of amino unit substitutions which comprise said anionic moiety is less than or equal to the number of quaternized backbone amino units; b) from about 0.00005% by weight, of a xyloglucanase enzyme; c) from about 0.

Abstract: The present invention relates to novel ether compounds, compositions comprising ether compounds, and methods useful for treating and preventing cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders comprising administering a composition comprising an ether compound. The compounds, compositions, and methods of the invention are also useful for treating and preventing Alzheimer's Disease, Syndrome X, peroxisome proliferator activated receptor-related disorders, septicemia, thrombotic disorders, obesity, pancreatitis, hypertension, renal disease, cancer, inflammation, and impotence. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.

Abstract: The present invention relates to a synthesis method of thionate diamine by the reaction of alkali metal isethionate with diols to form alkali metal isethionate ethoxylate having the following structural formula:HO(CH.sub.2 CH.sub.2 O).sub.n CH.sub.2 CH.sub.2 SO.sub.3 AThe above isethionate ethoxylate is then reacted with aliphatic diamine having a Carbon number of 2 to 6 to form a series of N-(2-aminoalkyl)-2-aminoethyoxylate ethane sulfonate having the following structure formula:H.sub.2 N--(CH.sub.2).sub.m --NH--(CH.sub.2 CH.sub.2 O).sub.n CH.sub.2 CH.sub.2 SO.sub.

Abstract: The present invention relates to compounds of the formula 1 ##STR1## wherein R.sub.1 is selected from hydrogen and -R.sub.4 -R.sub.5 where R.sub.4 is selected from nothing C.sub.1 -C.sub.20 linear or branched alkylene C.sub.3 -C.sub.20 cycloalkylene, C.sub.6 -C.sub.20 arylene, C.sub.7 -C.sub.20 alkarylene and C.sub.7 -C.sub.20 arlkylene; and R.sub.5 is one of hydrogen, hydroxy, --CO.sub.2 Z, phenyl hydroxyphenyl pyridyl, nitrophenyl, furyl, and thienyl; R.sub.2 and R.sub.3 are independently selected from a group of the formula --R.sub.4 --R.sub.6 ; where R.sub.4 is as defined above and R.sub.6 is one of hydrogen, hydroxy --CO.sub.2 Z. --CH(CO.sub.2 Z)--CH.sub.2 --CO.sub.2 Z and NR.sub.7 R.sub.8 ; where R.sub.7 and R.sub.8 are independently selected from a group of the formula: --(CH.sub.2)k--R.sub.g : where k.dbd.0-20 and R.sub.g is one of hydrogen, hydroxy, --CO.sub.2 Z. and --CH(CO.sub.2 Z)--CH.sub.2 --CO.sub.2 Z: wherein Y is selected from --CO.sub.2 Z. --SO.sub.3 Z and --C.dbd.

Abstract: Distillate fuel is treated with additives whose structure match the crystal planes of the wax which crystallizes from the fuel to produce crystals below 4000 nanometres in size, suitable additive include novel sulpho-carboxylic materials particularly their esters and amine derivatives such as the amine salts and/or amides of ortho-sulpho benzoic acid.

Abstract: Substituted hydroxylamines useful in photographic processing solution can be prepared by reacting a hydroxylamine with a vinylic compound having an electron withdrawing substituent in a suitable solvent, in the absence of a neutralizing base. The resulting products can be used without isolation from the reaction solution.

Abstract: A method for the manufacture of N,N dialkylglycamine compounds of general formula R.sub.2 NR.sub.1 R.sub.3 (I) by reacting a secondary amine of general formula R.sub.2 NHR.sub.3 (II) in which R.sub.2 is a straight or branched chain alkyl or hydroxyalkyl group having from 1 to 4 carbon atoms and R.sub.3 is a residue from a monosaccharide, with an alkali metal or alkaline earth metal aliphatic sulphate, R.sub.1 SO.sub.4 M, in which R.sub.1 is a straight or branched chain alkyl or alkenyl group having from 8 to 24 carbon atoms.The betaine, suphobetaine and N-oxidised derivatives of (I) are provided for use as mild surfactants.

Abstract: The present invention relates to a pharmaceutical composition for use in preventing or treating heart diseases in a mammal, which comprises at least one aminoalkanesulfonic acid derivative of the formula (I): ##STR1## wherein X is hydrogen or an amino acid residue; Y is hydrogen, a phenyl group or an alkyl group, which may have a hydroxy, amino, carboxy, phenyl or hydroxyphenyl group; or X and Y are joined to form a trimethylene or hydroxytrimethylene group; and at least one of X and Y is other than hydrogen;or pharmaceutically acceptable salt thereof.

Abstract: There is provided a process for producing sulfoalkyl-substituted hydroxylamines useful as preservatives to be added to a color developer for photosensitive materials. In this process, the sulfoalkyl-substituted hydroxylamines can be easily synthesized by reacting a specified alkylating agent, cyclic sulfonic ester, vinylsulfonic acid or sulfoalkyl-substituted acrylamide with a hydroxylamine.

Abstract: There is provided a process for producing sulfoalkyl-substituted hydroxylamines useful as preservatives to be added to a color developer for photosensitive materials. In this process, the sulfoalkyl-substituted hydroxylamines can be easily synthesized by reacting a specified alkylating agent, cyclic sulfonic ester, vinylsulfonic acid or sulfoalkylsubstituted acrylamide with a hydroxylamine.

Abstract: The invention relates to alkyl ether carboxylic acid taurides of the formulaR.sup.2 --(OC.sub.2 H.sub.4).sub.n --O--CH.sub.2 --CO--NR.sup.1 --C.sub.2 H.sub.4 --SO.sub.3 M,in which n is greater than 0, R.sup.1 =H or C.sub.1 -C.sub.4 alkyl, R.sup.2 =C.sub.5 -C.sub.22 alkyl and M=H, Na, K, Ca/2 or Mg/2.Processes for their preparation and their use as surface-active substances, especially as mild cleaning agents for cosmetic purposes, are also described.

Abstract: The present invention provides a novel betaine compound represented by the general formula: ##STR1## wherein R.sup.1 is a straight-chain or branched alkyl, alkenyl or hydroxyalkyl group having 8 to 22 carbon atoms; X is H or a hydroxyl group; R.sup.2, R.sup.3 and R.sup.4 each represent an alkyl group having 1 to 4 carbon atoms; Y is --CH.sub.2 CH(OH)CH.sub.2 SO.sub.3, --(CH.sub.2).sub.n SO.sub.3 or --(CH.sub.2).sub.m CO.sub.2 ; n is 2 to 5; m is 1 to 5; and l is 0 to 5; a process for the preparation of the same; and a detergent composition containing the same. This detergent composition exhibits excellent foaming power and detergency and is lowly irritant, thus being suitable for a base of a body or hair shampoo.

Abstract: Bisulfite addition products, which exhibit surface active properties, prepared by reacting a ketone-terminated polyoxyalkylene compound, such as a diketone of a polyoxypropylene glycol, a monoketone of a polyoxyalkylene alcohol, etc. with an ammonium or alkali metal bisulfite are disclosed.

Abstract: The new compounds have the formula below ##STR1## in which R.sub.f is a perfluoroalkyl radical having 4 to 20 carbon atoms,x is 1 to 4,y is 1 to 10,X is Br, Cl or I, andR.sup.1 and R.sup.2 are hydrogen or a C.sub.1 to C.sub.4 -alkyl radical or a water-solubilizing aliphatic radical, with the proviso that at least one of the two substituents R.sup.1 and R.sup.2 is a water-solubilizing aliphatic radical.The surface-active compounds described are prepared by reacting a suitable epoxide with a suitable amine. They are used in particular for the preparation of foaming agents.

Abstract: The present invention provides a novel betaine compound represented by the general formula: ##STR1## wherein R.sup.1 is a straight-chain or branched alkyl, alkenyl or hydroxyalkyl group having 8 to 22 carbon atoms; X is H or a hydroxy group; R.sup.2, R.sup.3 and R.sup.4 each represent an alkyl group having 1 to 4 carbon atoms; Y is --CH.sub.2 CH(OH)CH.sub.2 SO.sub.3, --(CH.sub.2).sub.n SO.sub.3 or --(CH.sub.2).sub.m CO.sub.2 ; n is 2 to 5; m is 1 to 5; and l is 0 to 5; a process for the preparation of the same; and a detergent composition containing the same. This detergent composition exhibits excellent foaming power and detergency and is lowly irritant, thus being suitable for a base of a body or hair shampoo.

Abstract: A method for forming microcapsules by enwrapping an oily core material in a formaldehyde condensation product formed in situ wherein a dispersant is used of the formula (I): ##STR1## where: M is an alkali metal cation or a quaternary ammonium group,L is --(CH.sub.2).sub.p, --COO(CH.sub.2).sub.p, --C.sub.6 H.sub.4 -- or a direct bond;R, R.sup.2 and R.sup.6 are the same or different and represent a hydrogen atom or a methyl group;R.sup.1 is a hydrogen atom, an alkyl group having 1 to 4 carbon atoms, or --SO.sub.3 M where M is defined as above; R.sup.3 is --COOR.sup.4, --CONHR.sup.4, --CO--R.sup.4, a pyridinyl group or quaternary salt thereof, --COOCH.sub.2 CH.sub.2 N(CH.sub.3).sub.2 --, --COOCH.sub.2 CH.sub.2 N.sub.4 (CH.sub.3).sub.3 Cl-- group having 1 to 12 carbon atoms, an aralkyl group, an aryl group, or --(CH.sub.2).sub.m --OOC--CR.sup.2 CH.sub.2, --(OCH.sub.2 CHhd 2).sub.m COO--CR.sup.2 CH.sub.2 or --(CH.sub.2).sub.m NHCO--CR.sup.2 CH.sub.2 ;x is about 0.4 to 0.8;y is about 0.2 to 0.6;z is about 0 to 0.

Abstract: A C-branched zwitterionic surfactant represented by the following formula is disclosed: ##STR1## wherein x and y are numbers, x is less than or equal to y+1, and the sum of x+y in the range of about 7 to about 19, with the provisos that: (1) when the sum of x+y is in the range of about 7 to about 13, x/y is in the range of about 0.3 to about 1.2; and (2) when the sum of x+y is in the range of about 14 to about 19, x/y is in the range of about 0.1 to about 0.7. An enhanced oil recovery method using the foregoing surfactants is also disclosed.

Abstract: Novel surface active agents of the formula: ##STR1## wherein R is selected from the group consisting of alkyl, aryl, alkylaryl groups of 2-18 carbons and alkoxymethyl wherein the alkoxy group is of 2-18 carbon atoms,R.sup.2 and R.sup.3 are individually selected from the group consisting of methyl; alkyl of 2 to 6 carbon atoms wherein said alkyl group is substituted by an electron-donating group on the beta carbon atoms thereof; polyoxyethylene and polyoxypropylene or R.sup.2 R.sup.3 may jointly form a --CH.sub.2 CH.sub.2 OCH.sub.2 CH.sub.2 -- or CH.sub.2 CH.sub.2 SCH.sub.2 CH.sub.2 -- group so as to form, together with the nitrogen atom to which they are bound, to form a morpholine or thiomorpholine ringQ is a covalent bond or ##STR2## wherein R.sup.1 is independently selected from the same groups as R.sup.2 and R.sup.

Abstract: Propane or butane sultones are prepared by the thermal decomposition of the corresponding aryl sulfoalkyl ethers wherein the alkyl part has three or four carbons between the sulfo group and the ether oxygen. When a tertiary amine is present, the final product is the corresponding sulfoalkyl quaternary salt of the tertiary amine.

Abstract: A C-branched zwitterionic surfactant represented by the following formula is disclosed: ##STR1## wherein x and y are numbers, x is less than or equal to y+1, and the sum of x+y is in the range of about 7 to about 19, with the provisos that: (1) when the sum of x+y is in the range of about 7 to about 13, x/y is in the range of about 0.3 to about 1.2; and (2) when the sum of x+y is in the range of about 14 to about 19, x/y is in the range of about 0.1 to about 0.7. An enhanced oil recovery method using the foregoing surfactants is also disclosed.